KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teladoc Health (TDOC) Common Equity (2016 - 2025)

Teladoc Health's Common Equity history spans 13 years, with the latest figure at $1.4 billion for Q4 2025.

  • For Q4 2025, Common Equity fell 7.07% year-over-year to $1.4 billion; the TTM value through Dec 2025 reached $1.4 billion, down 7.07%, while the annual FY2025 figure was $1.4 billion, 7.07% down from the prior year.
  • Common Equity for Q4 2025 was $1.4 billion at Teladoc Health, roughly flat from $1.4 billion in the prior quarter.
  • Across five years, Common Equity topped out at $16.0 billion in Q4 2021 and bottomed at $1.4 billion in Q4 2025.
  • The 5-year median for Common Equity is $2.3 billion (2023), against an average of $5.5 billion.
  • The largest annual shift saw Common Equity surged 1482.67% in 2021 before it tumbled 85.62% in 2022.
  • A 5-year view of Common Equity shows it stood at $16.0 billion in 2021, then crashed by 85.62% to $2.3 billion in 2022, then rose by 0.79% to $2.3 billion in 2023, then plummeted by 35.9% to $1.5 billion in 2024, then fell by 7.07% to $1.4 billion in 2025.
  • Per Business Quant, the three most recent readings for TDOC's Common Equity are $1.4 billion (Q4 2025), $1.4 billion (Q3 2025), and $1.4 billion (Q2 2025).